These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1364719)

  • 1. [Fluoroquinolones].
    Lumio J
    Duodecim; 1991; 107(10):757-64. PubMed ID: 1364719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quinolones: significance and problems in the clinic and in general practice].
    Daschner F; Kappstein I
    Internist (Berl); 1988 Mar; 29(3):206-12. PubMed ID: 2837440
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial internalization and intracellular activity of quinolones and macrolides].
    Bellussi L; De Benedetto M; Lauriello M; Passali GC; Passali D
    Acta Otorhinolaryngol Ital; 2007 Apr; 27(2 Suppl 87):1-11. PubMed ID: 17702375
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of the quinolones.
    Andersson MI; MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone resistance: mechanisms and epidemiology.
    Tillotson GS; Dorrian I; Blondeau J
    J Med Microbiol; 1997 Jun; 46(6):457-61. PubMed ID: 9379475
    [No Abstract]   [Full Text] [Related]  

  • 7. [New quinolones].
    Matsumoto F; Morita M; Sato Y
    Nihon Rinsho; 1990 Oct; 48(10):2205-11. PubMed ID: 2177796
    [No Abstract]   [Full Text] [Related]  

  • 8. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist].
    Schurz JK
    Pharm Unserer Zeit; 2001; 30(5):400-5. PubMed ID: 11575176
    [No Abstract]   [Full Text] [Related]  

  • 10. First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.
    Liassine N; Zulueta-Rodriguez P; Corbel C; Lascols C; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2008 Nov; 62(5):1151-2. PubMed ID: 18669519
    [No Abstract]   [Full Text] [Related]  

  • 11. [How can we protect against broad-band pathogens? The situation with quinolone resistance].
    Kresken M; Hafner D
    Pharm Unserer Zeit; 2001; 30(5):436-45. PubMed ID: 11575181
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review [new antimicrobial agent series XLI]: lomefloxacin].
    Soejima R; Matsumoto F
    Jpn J Antibiot; 1991 Oct; 44(10):1045-60. PubMed ID: 1662290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Usefulness of pharmacokinetic and pharmacodynamic parameters fro establishing the optimal dosage of antibacterials].
    Gomis Gavilán M; Prieto Prieto J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):104-12. PubMed ID: 7711116
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
    Cuffini AM; Tullio V; Vaiani G; Carlone NA
    J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on cross-resistance of fluoroquinolones.
    Garau J
    Int J Clin Pract Suppl; 2000 Dec; (115):94-8. PubMed ID: 11219309
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical impact of in vitro data with newer quinolones.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):662-3. PubMed ID: 16312581
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent progress in antimicrobial agents].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1988 Oct; 77(10):1519-23. PubMed ID: 2854150
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in bacterial topoisomerase inhibitors.
    Bradbury BJ; Pucci MJ
    Curr Opin Pharmacol; 2008 Oct; 8(5):574-81. PubMed ID: 18555745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quinolones. Gyrase inhibitors].
    Höffler D
    Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
    [No Abstract]   [Full Text] [Related]  

  • 20. Are the quinolones realising their clinical potential?
    Ball P
    J Chemother; 1989 Jul; 1(4 Suppl):664-5. PubMed ID: 16312582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.